T HE diagnosis and management of total anomalous pulmonary venous connection (TAPVC) continues to be one of the most difficult and provocative problems encountered by the pediatric cardiologist and cardiovascular surgeon. The purpose of this paper is to review and correlate the clinical, From Supported in part by Grant HE 5310-10 from the National Heart and Lung Institute of the National examination in 54, at cardiac catheterization and subsequently confirmed at operation in 17, and at cardiac catheterization alone in the remaining four. An atrial septal defect (ASD) or patent foramen ovale (PFO) was considered to be a necessary component of the basic defect. Twenty patients included also had a probe patent or functionally patent ductus arteriosus (PDA); all 20 were less than 4 months of age.
The clinical material was divided by age and level of pulmonary artery pressure (table 1) . Sixty-nine patients were first examined when less than 1 year of age. Fifty-two of these had evidence, physiologic or pathologic, or both, of pulmonary artery hypertension (PAH). The pulmonary artery systolic pressure was at least half the systemic pressure in 35 of the patients who were catheterized. Right ventricular hypertension at systemic levels without autopsy evidence of right ventricular outflow obstruction was present in an additional three infants. Indirect evidence of pulmonary hypertension in the remaining 14 cases was based either on gross pathologic pulnonary venous obstruction (11 cases) , in seven of which the pulmonary vein drained into the portal vein (PV), or histologic evidence of severe medial and intimal proliferation of the arterioles (three cases).
Forty-two of the 52 infants with PAH also had pulmonary vascular obstruction (PVO). Almost all of these had anatomic or physiologic evidence of pulmonary venous obstruction proven at cardiac catheterization or postmortem examination.
Seventeen infants under 1 year of age had pulmonary artery pressures which were less than half the systemic pressure and were therefore considered not to have significant PAH. None had evidence of PVO either at catheterization or postmortem examination.
Only six patients (8% of our total series) had no cardiac evaluation before they were 1 year of age. All underwent catheterization at a later date (one at 23 months, four between 4 and 6 years, and one at 16 years). Five of the six had pulmonary artery pressures less than half the systemic pressure. In the remaining patient the pulmonary artery was not entered, but the right ventricular pressure was 100 mm Hg. Pressure in The birth weight of our patients ranged from 3 to 9 lbs 11 oz. The average birth weight of males was 7 lbs while that of females was 6 lbs 13 oz, both at the 25th percentile. Nine patients (12%) weighed less than 2,500 g at birth.
All the babies who were seen before they were 1 year of age were scrawny. Most had gained little weight since birth. Of the 39 who survived to 3 months of age, only five, all of them without significant PAH, were above the 10th percentile for weight. Chest deformities were rare in the infant group, although the right ventricular impulse was hyperkinetic in the majority. Pulmonary rales were noted in 14 patients, all with PAH. Forty-four of the 53 patients with significant PAH, irrespective of the drainage site, had hepatomegaly (liver extended more than 3 cm below the right costal margin). More than half of the non-PAH group also had some enlargement of the liver. The femoral pulses were normal in all but those in extremis.
The majority of these patients were examined by one of us (A.S.N.). The auscultatory findings described below represent the findings of the most senior cardiologist who examined each patient. The first heart sound was usually well audible, often loud. Sixty to recognize that pulmonary artery saturation and systemic artery saturation in TAPVC may not be equal (in our most extreme case the PA saturation was 90% compared with a systemic saturation of 69%). PA LSVC  26  1  10  1  14  RSVC  8  2  6  Cs  14  4  6  3  1  RA  3  3   Subdiaphragmatic   16  16  Mixed  8  3  2  3  Total  75  1  22  9  3  40 Circulation, Volume XLII, July 1970 P.C. Pulmonary Vascular Obstruction and Pulmonary Venous Obstruction. The vast majority of patients with PAH had pulmonary vascular obstruction (PVO) (43/52; table 6), and of those with PVO, 40 had pulmonary venous obstruction. Those with LSVC drainage most frequently had a definite narrowing of the trunk as it crossed the left bronchus. With RSVC drainage the site of obstruction uniformly occurred at the junction of the anomalous trunk with the RSVC and in one of our cases this junction was only 1 mm in diameter. One of our patients with CS drainage had stenosis of the individual pulmonary veins prior to their entrance into the CS.
Of those 16 patients with subdiaphragmatic
Circulation, Volume XLII, July 1970 drainage six had stenosis at the diaphragm, and 10 had stenosis as the trunk entered the portal vein or ductus venosus which was uniformly closed in our postmortem specimens. Of the three patients with PVO who did not have pulmonary venous obstruction demonstrated at autopsy, by pressure data, or by angiogram, all had PAH, low pulmonary blood flow, and marked medial and intimal arteriolar proliferation (in these cases the arterioles were described as "angiomatous"). and more careful postoperative respiratory care will undoubtedly improve these discouraging statistics.
Discussion
The majority of patients with TAPVC in the pediatric age group will present with cyanosis and CHF within the first 3 months of life. Only an occasional patient (8% in our series) will survive to 1 year of age without significant signs or symptoms pointing to the presence of congenital heart disease.
An aggressive diagnostic approach has led to the early recognition of this defect, and at this institution more than 80% of the patients with proven TAPVC have had catheterization in the period since 1950. We now understand that PVO is an important feature of this defect and also that anatomic obstruction to pulmonary venous return can occur with anomalous return to any site. Pulmonary venous obstruction can be diagnosed by evaluation of pressure and flow data or by the actual visualization of a site of narrowing in the pulmonary venous trunk in the angiogram. We have not been able to document significant obstruction to venous return at the atrial septal level. In 40 of 43 patients with PVO a hemodynamically significant point of pulmonary venous obstruction was visualized on angiogram, proven by pressure data at catheterization, or defined at gross postmortem examination. These observations suggest that creation of an atrial septal defect (Rashkind21 or Blalock-Hanlon22) in these patients would result in no significant hemodynamic improvement and may only postpone to a later, less favorable time, the inevitable curative surgical approach. The inherent additional hazard of systemic embolization with the use of the balloon catheter has been described elsewhere. 23 On the basis of our observations, we suggest the following approach to the management of this defect.
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